ANACOR PHARMACEUTICAL
Anacor Pharmaceuticals is a biopharmaceutical company that engages in developing small-molecule therapeutics from its boron chemistry platform. It focuses on developing topical applications of its compounds to treat fungal, bacterial, and inflammatory diseases. The companyรขโฌโขs primary product candidate, AN2690, is a novel topical antifungal for the treatment of toenail onychomycosis, a fungal infection of the nail and nail bed. It is also developing AN2728, an anti-inflammatory product candidate for the treatment of psoriasis; AN0128, a product candidate that has antibiotic and anti-inflammatory properties; and AN2718, which is in preclinical development for the topical treatment of vaginal candidiasis and tineapedis.
ANACOR PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2000-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.anacor.com
Total Employee:
51+
Status:
Active
Contact:
(650) 543-7500
Email Addresses:
[email protected]
Total Funding:
448.35 M USD
Technology used in webpage:
SPF Domain Not Resolving Proofpoint Dyn DNS Internet Names For Business XO Communications Dyn Hosting HTML Tidy
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Innovation Pharmaceuticals
Innovation Pharmaceuticals is a biopharmaceutical company developing small molecule therapies in areas of unmet medical needs.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Guardian Pharmacy
Guardian Pharmacy is a pharmacy company provide outstanding client service to long-term care facilities.
Icon Bioscience
Icon Bioscience develops and commercializes novel ophthalmic pharmaceuticals through a proprietary drug delivery platform.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Laurent Pharmaceuticals
Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
NuPathe
NuPathe is a pharmaceutical company developing solutions for diseases of the CNS, including neurological and psychiatric disorders.
Oncolix
Oncolix is a clinical-stage bio-pharmaceutical company developing a therapeutic protein for the treatment of cancer.
OncoMed Pharmaceuticals
OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.
Pacira Pharmaceuticals
Pacira Pharmaceuticals is a specialty pharmaceutical company dedicated to postsurgical innovation.
PharmAkea Therapeutics
PharmAkea is a biopharmaceutical company developing small molecule drug candidates targeting proteins in fibroproliferative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Ryvu
Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals is a discovery company developing a new class of pharmaceuticals called small molecule nucleic acid hybrids.
Synergy Pharmaceuticals
Synergy Pharmaceuticals is a biopharmaceutical company developing novel therapies for the treatment of gastrointestinal conditions.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
XyloCor Therapeutics
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Anacor Pharmaceutical
Ling Wong
Ling Wong investment in Post-IPO Equity - Anacor Pharmaceutical
U.S. Department of the Treasury
U.S. Department of the Treasury investment in Grant - Anacor Pharmaceutical
GSK
GSK investment in Venture Round - Anacor Pharmaceutical
Rho Capital Partners
Rho Capital Partners investment in Series E - Anacor Pharmaceutical
Schering AG
Schering AG investment in Series E - Anacor Pharmaceutical
Aberdare Ventures
Aberdare Ventures investment in Series E - Anacor Pharmaceutical
GSK
GSK investment in Series E - Anacor Pharmaceutical
Venrock
Venrock investment in Series E - Anacor Pharmaceutical
Care Capital
Care Capital investment in Series E - Anacor Pharmaceutical
Official Site Inspections
http://www.anacor.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102